Medications - Page 125

October 28, 2015

FDA approves new oral MS drug, Tecfidera

U.S. regulators approved a new multiple sclerosis drug made by Biogen Idec Inc that is widely expected to become the No. 1 oral treatment for the disease, with annual sales topping $3 billion

October 28, 2015

Few US stroke patients get clot-busting treatment

Not all U.S. stroke patients eligible for a clot-busting treatment actually receive it - and the odds of getting this therapy may depend on where they live, a large study finds.

October 28, 2015

Amoxicillin doesn’t help some respiratory infections

The next time you develop a lower respiratory tract infection, don't expect amoxicillin, the go-to antibiotic for these infections, to wipe it out

October 28, 2015

FDA approves easy-to-use heroin overdose antidote

The government is taking a step to let friends or loved ones treat someone they suspect has overdosed on heroin or powerful painkillers called opioids, while they're waiting for medical care.

October 27, 2015

Indian-made medicines spark safety concerns

A number of Indian pharmaceutical companies are receiving criticism from the U.S. Food and Drug Administration (FDA) over increased lapses in quality and safety of their products.

October 27, 2015

Merck KGaA revives testing of lung cancer vaccine

German drugmaker Merck KGaA will conduct new tests on an experimental lung cancer vaccine which failed a previous late-stage clinical trial, it said on Wednesday.

October 27, 2015

Combined supplements no better for cholesterol

The cholesterol-lowering agent red yeast rice, an alternative treatment method for patients that can't tolerate statin drugs, doesn't work any better when a plant-derived compound called sterol is added to it, according to a new study. 

October 27, 2015

Progesterone treatment fails to minimize brain trauma, studies find

Two large studies of patients with serious brain injuries found that giving people the hormone progesterone soon after injury didn’t minimize the effects of brain trauma.

October 27, 2015

The 5 most common medications in the US and how to save on them

Prescription spending went through the roof in 2014 in the United States.

October 27, 2015

Last-line antibiotics losing ability to kill superbugs in EU

Europe faces a growing threat from superbugs that are resistant to a powerful, last-resort class of antibiotics known as carbapenems, the EU's disease monitoring agency said on Friday.